sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a disclosure under Form 8.3 related to their position in Mural Oncology plc. As of June 3, 2025, Vanguard holds interests in 772,899 ordinary shares of Mural Oncology, representing 4.48% of the company's securities. This disclosure complies with the Irish Takeover Panel Act, 1997, and updated Takeover Rules of 2022.
Vanguard's disclosure covers ownership and does not include short positions in the specified securities. No additional parties involved in the transaction are mentioned, indicating focus solely on Mural Oncology. A minimal transaction was reported: Vanguard sold 32 ordinary shares at a price of 2.63 USD per unit.
No supplemental agreements or derivatives are associated with this disclosure, and Vanguard confirms no indemnities or arrangements that could influence securities dealings.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.